What are the active and inactive ingredients in Ritalin (methylphenidate) tablets and Ritalin LA (extended‑release) capsules?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Ritalin Components

Ritalin tablets contain methylphenidate hydrochloride as the active ingredient, with inactive ingredients including lactose, magnesium stearate, polyethylene glycol, starch (in 5-mg and 10-mg tablets), sucrose, talc, tragacanth (in 20-mg tablets), and specific dyes: D&C Yellow No. 10 (in 5-mg and 20-mg tablets) and FD&C Green No. 3 (in 10-mg tablets). 1

Active Ingredient

  • Methylphenidate hydrochloride (MPH): A CNS stimulant with molecular weight of 269.77 g/mol
  • Chemical name: methyl α-phenyl-2-piperidineacetate hydrochloride
  • Physical properties: white, odorless, fine crystalline powder that is freely soluble in water and methanol, soluble in alcohol, and slightly soluble in chloroform and acetone 1

Inactive Ingredients by Tablet Strength

5-mg tablets contain:

  • D&C Yellow No. 10 (dye)
  • Lactose
  • Magnesium stearate
  • Polyethylene glycol
  • Starch
  • Sucrose
  • Talc

10-mg tablets contain:

  • FD&C Green No. 3 (dye)
  • Lactose
  • Magnesium stearate
  • Polyethylene glycol
  • Starch
  • Sucrose
  • Talc

20-mg tablets contain:

  • D&C Yellow No. 10 (dye)
  • Lactose
  • Magnesium stearate
  • Polyethylene glycol
  • Sucrose
  • Talc
  • Tragacanth 1

Ritalin LA (Extended-Release) Components

Ritalin LA capsules contain the same active ingredient (methylphenidate HCl) but different inactive ingredients designed for extended release:

  • Ammonio methacrylate copolymer
  • Gelatin
  • Methacrylic acid copolymer
  • Polyethylene glycol
  • Sugar spheres
  • Talc
  • Titanium dioxide
  • Triethyl citrate
  • Color-specific ingredients:
    • Black iron oxide (10 mg and 40 mg capsules)
    • Red iron oxide (10 mg and 40 mg capsules)
    • Yellow iron oxide (10 mg, 30 mg, and 40 mg capsules) 2

Key Formulation Differences

The extended-release Ritalin LA formulation uses a bimodal delivery system with coated beads that provides two distinct peak plasma concentrations approximately 4 hours apart, mimicking the effect of immediate-release methylphenidate given twice daily 3, 4. This allows for once-daily dosing while maintaining therapeutic coverage throughout the day.

References

Related Questions

How should Concerta (extended-release methylphenidate) be dosed and administered?
How many hours does Ritalin LA (long‑acting methylphenidate) last?
Does Ritalin LA (methylphenidate) still exert pharmacologic effects 18 hours after a dose?
What is the appropriate Concerta (methylphenidate) dosing schedule for an adult weighing 37 kg?
What is the recommended starting dose of Ritalin (methylphenidate) in adults?
Can coffee (caffeine) be used to treat ADHD, and what is a safe daily amount?
For a patient with irritability and no known contraindications, is sertraline (Zoloft) or escitalopram (Lexapro) the better treatment option?
What is the appropriate diagnostic workup and acute and preventive management for hemiplegic migraine?
What is the first‑line antiepileptic drug for a 26‑year‑old woman with a witnessed generalized tonic‑clonic seizure, a four‑year history of epilepsy, not currently on any antiepileptic medication, primary generalized tonic‑clonic seizures, no clinical features of juvenile myoclonic epilepsy, and a normal electroencephalogram?
How should a 50-year-old woman with an estimated glomerular filtration rate of 69 mL/min/1.73 m² be managed, including monitoring and medication dosing?
How should I manage a middle‑aged patient with moderate obstructive sleep apnea (apnea‑hypopnea index 27, nadir oxygen saturation 72%) who cannot tolerate continuous positive airway pressure, has frequent leg movements and restless‑leg symptoms improved by magnesium supplementation, normal ferritin, and is taking sertraline and lamotrigine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.